showed a trendP < 0.05
Fasting plasma glucose levels between weeks 0 and 12 decreased similarly in control group ( P < 0.05) and vildagliptin group ( P < 0.05); HbA1c levels showed a trend to decrease in both groups ( P < 0.05).
Fasting plasma glucose levels between weeks 0 and 12 decreased similarly in control group ( P < 0.05) and vildagliptin group ( P < 0.05); HbA1c levels showed a trend to decrease in both groups ( P < 0.05).